Bio-Techne

Bio-Techne is Helping Scientists Discover Answers about SARS-CoV-2 and COVID-19

Via R&D Systems “Sequencing of SARS-CoV-2 showed that it is ~80% identical to SARS-CoV, the CoV responsible for the SARS pandemic in 2002.1,2 Studies have also shown that it also utilizes the same cell surface receptor as SARS-CoV to gain entry into the host cell, which is Angiotensin-Converting Enzyme 2 (ACE-2). Additionally, the viral spike (S) […]

Bio-Techne’s Ella on the Front Lines in Fight Against COVID-19

MINNEAPOLIS, March 25, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today shared news from clinical partners on the use of the ProteinSimple™-branded Ella™ Automated Immunoassay platform in the fight against COVID-19.   In a March 23, 2020 press release, the Icahn School of Medicine, Mount Sinai announced that they are utilizing Bio-Techne’s Ella Automated Immunoassay Platform to monitor […]

In the Know: Healthcare News for March 23, 2020

Ed. note: Without question the biggest story of the week is — and for the foreseeable future will be — COVID-19 and what companies are doing in response. We have collected all of those stories at medicalalley.org/covid19. We still want to highlight the other life-changing work being done by Medical Alley companies during this time, […]

In the Know: Healthcare News for Jan. 27, 2019

Manny Villafaña raising $10 million for Medical 21 BREAKING: Medtronic wins FDA approval for Micra AV Three Industry Leaders Form New Venture to Create Scalable Manufacturing Platforms for Cell and Gene Therapies Major Texas health system will use CHF Solutions’ Aquadex FlexFlow system Starkey’s Livio Hearing Aid Has New AI Capabilities Spotlight: Flywheel leaves science […]

In the Know: Healthcare News for December 23, 2019

House passes measure to kill medical device tax Bright Health Raises $635M in Latest Funding Round Boston Scientific gets 1st US disposable duodenoscope clearance Medtronic Acquires Klue In a first, researchers sequence single bacterial cells, paving path for rapid sepsis test Faegre Baker Daniels will merge with large Philadelphia law firm on Feb. 1 Ecolab […]

In the Know: Healthcare News from Medical Alley for December 9, 2019

John Halamka named president of Mayo Clinic Platform NeuroOne Medical Technologies Corporation Receives FDA 510(k) Clearance for Evo(TM) Cortical Electrode Abilitech Medical raises $7.4 million Dr. Craig Samitt Headlines Medical Alley Representation on TCB 100 List Boston Scientific sells Zytiga royalties for $256m Case report: Stem cells a step toward improving motor, sensory function after […]

In the Know: Healthcare News for Nov. 4, 2019

Bio-Techne will open $40M+ facility in St. Paul IBM, Mayo Clinic, Geisinger among 25 finalists for $1.6M CMS artificial intelligence challenge Medtronic wins FDA breakthrough nod for fully implantable LVAD Minnesota Startups Raised $70.8M in Q3 Boston Sci Gives Update on the Measured Launch of Lotus Edge Meet The Most Disruptive MBA Startups Of 2019 […]

In the Know: Healthcare News for October 14, 2019

Phase 2 Results: Microbiota-Based RBX2660 Safe, Efficacious for Preventing C diff Recurrence Medtronic Bids for FDA Approval of OAB/FI Neuromodulation Device – MassDevice Recombinetics Announces Collaboration with Mayo Clinic to Develop the First-Ever Swine Models of Osteogenesis Imperfecta This Is the Strongest Pipeline in Medtronic’s History Funding Roundup: 4C Medical Spineology Seek Millions West Monroe […]

Medicare Issues Final Local Coverage Decision for Bio-Techne’s ExoDx Prostte (IntelliScore) Test

MINNEAPOLIS, Oct. 10, 2019/PRNewswire/ – Bio-Techne Corporation (NASDAQ:TECH) today announced that the Medicare Administrative Contractor (MAC) National Government Services, Inc. issued a final Local Coverage Decision (LCD) covering the ExoDx Prostate(IntelliScore) – EPI – test for men who are being considered for an initial prostate biopsy. The decision is effective for tests administered on or […]

Bio-Techne Leverages the RNAscope Technology to Advance a Multiomic Approach to Antibody Validation

MINNEAPOLIS, Oct. 7, 2019/PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, has been validating a growing number of immunohistochemistry (IHC) antibodies using the Advanced Cell Diagnostics-branded RNAscope in situ hybridization (ISH) platform to leverage its transcriptomics approach […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER